RAD001 in Combination With CP-751,871 in Patients Wtih Advanced Sarcomas and Other Malignant Neoplasms
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to determine the safety of the combination of RAD001
and CP-751,871, as well as the highest dose of this combination that can be given to people
safely. RAD001 is a newly discovered drug that may stop cancer cells from growing abnormally.
This drug has been extensively studied in many cancers. In particular, it has shown to be
effective in slowing down the growth of kidney cancer. CP-751,871 is another newly discovered
drug that may stop tumor growth. It is currently being studied in a wide variety of cancers,
and information from those other research studies suggests that these two drugs in
combination may help to stop cancer growth.